Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery

Journal of Pediatrics

Volumn 148, Issue 3, 2006, Pages 372-376

  Gessler, Peter ^a,b   Knirsch, Walter ^a,b   Schmitt, Bernhard ^a,b   Rousson, Valentin ^a,b   von Eckardstein, Arnold ^a,b  

^a Department of Pediatrics   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INOTROPIC AGENT; LACTIC ACID; TROPONIN T;

ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CYANOTIC HEART DISEASE; DISEASE DURATION; HUMAN; INFANT; LACTATE BLOOD LEVEL; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CHILD; CHILD, PRESCHOOL; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; LACTIC ACID; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; OUTCOME ASSESSMENT (HEALTH CARE); PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; TROPONIN;

EID: 33645973202     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.10.039     Document Type: Article

References (26)

1. Tuman K.J., McCarthy R.J., March R.J., Najafi H., and Ivankovich A.D. Morbidity and duration of ICU stay after cardiac surgery. A model for preoperative risk assessment. Chest 102 (1992) 36-44
2. Tu J.V., Jaglal S.B., and Naylor C.D. Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation 91 (1995) 677-684
3. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
4. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
5. Yeo K.T., Wu A.H., Apple F.S., Kroll M.H., Christenson R.H., Lewandrowski K.B., et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clinica Chimica Acta 338 (2003) 107-115
6. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
7. Richards A.M., Doughty R., Nicholls M.G., MacMahon S., Sharpe N., Murphy J., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 37 (2001) 1781-1787
8. Hutfless R., Kazanegra R., Madani M., Bhalla M.A., Tulua-Tata A., Chen A., et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43 (2004) 1873-1879
9. Jenkins K.J., Gauvreau K., Newburger J.W., Spray T.L., Moller J.H., and Iezzoni L.I. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123 (2002) 110-118
10. Klein Gunnewiek J.M., and van de Leur J.J. Elevated troponin T concentrations in critically ill patients. Intensive Care Med 29 (2003) 2317-2322
11. Dao Q., Krishnaswamy P., Kazanegra R., Harrison A., Amirnovin R., Lenert L., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37 (2001) 379-385
12. Hartmann F., Packer M., Coats A.J., Fowler M.B., Krum H., Mohacsi P., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure. a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110 (2004) 1780-1786
13. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
14. Hopkins W.E., Chen Z., Fukagawa N.K., Hall C., Knot H.J., and LeWinter M.M. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease. enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109 (2004) 2872-2877
15. Mir T.S., Marohn S., Laer S., Eiselt M., Grollmus O., and Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110 (2002) e760
16. Nir A., Bar-Oz B., Perles Z., Brooks R., Korach A., and Rein A.J. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 93 (2004) 603-607
17. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
18. Fede C., Frisina N., Caracciolo A., Buemi M., Caruso M.G., and Ricca M. Changes in plasma concentrations of atrial natriuretic peptide during the first ten days and the second month of life. Child Nephrol Urol 9 (1988) 144-146
19. Modi N., Betremieux P., Midgley J., and Hartnoll G. Postnatal weight loss and contraction of the extracellular compartment is triggered by atrial natriuretic peptide. Early Hum Dev 59 (2000) 201-208
20. Immer F.F., Stocker F., Seiler A.M., Pfammatter J.P., Bachmann D., Printzen G., et al. Troponin-I for prediction of early postoperative course after pediatric cardiac surgery. J Am Coll Cardiol 33 (1999) 1719-1723
21. Goetze J.P., Christoffersen C., Perko M., Arendrup H., Rehfeld J.F., Kastrup J., and Nielsen L.B. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17 (2003) 1105-1107
22. Berendes E., Schmidt C., Van Aken H., Hartlage M.G., Rothenburger M., Wirtz S., et al. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg 98 (2004) 11-19
23. Cuthbertson B.H., McKeown A., Croal B.L., Mutch W.J., and Hillis G.S. Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 33 (2005) 437-442
24. Kerbaul F., Giorgi R., Oddoze C., Collart F., Guidon C., Lejeune P.J., et al. High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery. Br J Anaesth 93 (2004) 639-644
25. Ma K.K., Ogawa T., and de Bold A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36 (2004) 505-513
26. Haug C., Metzele A., Steffgen J., Kochs M., Hombach V., and Grunert A. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Invest 72 (1994) 430-434